{"disease":{"id":"malignancies-multiple","name":"malignancies multiple"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01345019","title":"Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1718,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT06296368","title":"DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics","phase":"NA","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT04953065","title":"Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Monika Joshi","has_results":false},{"nct_id":"NCT07512505","title":"Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Our Lady's Hospice and Care Services","has_results":false},{"nct_id":"NCT02223598","title":"A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":120,"lead_sponsor_name":"Cleave Biosciences, Inc.","has_results":false},{"nct_id":"NCT02576496","title":"Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Mundipharma Research Limited","has_results":false},{"nct_id":"NCT01947140","title":"Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Jennifer Amengual","has_results":false},{"nct_id":"NCT03346837","title":"A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT01315132","title":"A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","has_results":true},{"nct_id":"NCT03263637","title":"Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT02722668","title":"UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":true},{"nct_id":"NCT02129582","title":"Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT02991898","title":"Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":true},{"nct_id":"NCT07071909","title":"Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}